Recombinant Human c-Abl His-tag Protein, CF

R&D Systems | Catalog # 11091-AL

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human c-Abl His-tag Protein (11091-AL)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

P00519.4

Applications

Enzyme Activity
View all c-Abl Proteins and Enzymes »

Product Specifications

Source

E. coli-derived human c-Abl protein
Gly227-Gln513, with an N-terminal Met and 6-His tag

Purity

>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

34 kDa

SDS-PAGE

33-35 kDa, under reducing conditions

Activity

Measured by its ability to phosphorylate the Abl peptide substrate EAIYAAPFAKKK.
The specific activity is >200 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human c-Abl His-tag Protein, CF

Recombinant Human c‑Abl His-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Human c‑Abl His-tag Protein (Catalog # 11091-AL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at ~33-35 kDa.

Formulation, Preparation, and Storage

11091-AL
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, TCEP and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: c-Abl

Tyrosine protein kinase ABL1 (Abelson murine leukemia viral oncogene homolog 1) is a ubiquitously expressed, magnesium-dependent, cytosolic member of the ABL subfamily of non-receptor protein tyrosine kinases (1). Human nonreceptor tyrosine kinases share a conserved domain structure that contributes to activity regulation and substrate specificity in many key processes linked to cell growth and survival (2-4). In addition, ABL1 contains domains unique to the ABL1 paralog that enable its function in DNA binding and DNA-damage response. ABL1 is composed of an N-terminal glycine myristoyl group that blocks the surface pocket of the kinase domain, a cap that stabilizes an inactive conformation, SH3 and SH2 domains that impose a locked inactive state, a protein kinase region, three nuclear localization signals, a DNA-binding region, and C-terminal nuclear export signal motifs, and actin F-binding domain (5-9). Activity is regulated through disruption of autoinhibitory interactions and several phosphorylation events that increase or decrease activity or promote function through stabilization (4). The SH2 domain contributes to both catalytic activity and target site specificity as has been shown with domain swapping (10). In chronic myelogenous, acute myeloid, and acute lymphoblastic leukemias, ABL1 is fused to BCR gene, resulting in deletion of the regulatory domains and production of a constitutively active tyrosine kinase (11). Several mutations in ABL1 lead to misregulation of activity in a variety of cancers (12).  ABL1 kinase inhibition is used for therapeutic treatment in leukemic cancers and requires further development of drugs to address ABL1-mutation conferred resistance (12,13). 

References

  1. Sefton, B.M. et al. (1981) Proc. Natl. Acad. Sci. USA 78:1552.
  2. Bradley, W.D. and A.J. Koleske (2009) J. Cell Sci. 122:3441.
  3. Gu, J.J. et al. (2009) Immunol. Rev. 228:170.
  4. Colicelli, J. (2010) Sci. Signal. 14:139.
  5. Wen, S.T. et al. (1996) EMBO J. 15:1853.
  6. Taagepera, S. et al. (1998) Proc. Natl. Acad. Sci. USA 95:7457.
  7. Pluk, H. et al. (2002) Cell. 108:247.
  8. Hantschel, O. et al. (2003) Cell. 112:845.
  9. Nagar, B. et al. (2006) Mol. Cell. 21:787.
  10. Filippakopoulos, P. et al. (2008) Cell. 134:793.
  11. Shtivelman, E. et al. (1986) Cell. 47:277.
  12. Wang, J. and A.M. Pendergast. (2015) Trends Cancer 1:110.
  13. Al Hamad, M. (2021) F1000Res. 10:1288. 

Long Name

Abelson Murine Leukemia Viral Oncogene Homolog 1

Alternate Names

ABL1, BCR-ABL1, bcr/abl, cAbl, JTK7

Entrez Gene IDs

25 (Human); 11350 (Mouse); 311860 (Rat)

Gene Symbol

ABL1

UniProt

P00519.4

Additional c-Abl Products

Product Documents for Recombinant Human c-Abl His-tag Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human c-Abl His-tag Protein, CF

For research use only

Customer Reviews for Recombinant Human c-Abl His-tag Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human c-Abl His-tag Protein, CF and earn rewards!

Have you used Recombinant Human c-Abl His-tag Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human c-Abl His-tag Protein, CF (11091-AL):

Materials
  • Universal Kinase Activity Kit (Catalog # EA004)
  • 10X Assay Buffer (supplied in kit): 250 mM HEPES, 1.5 M NaCl, 100 mM MgCl2, 100 mM CaCl2, pH 7.0 
  • Recombinant Human ABL-1 (rhABL-1) (Catalog # 11091-AL)
  • Substrate:  Abltide peptide (SignalChem, Catalog # A02-58), 1 mg/mL stock in 20 mM Tris, pH 7.5
  • 96-well Clear Plate (Catalog # DY990)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Prepare 1X Assay Buffer by diluting 10X stocks 10 fold with deionized water.
  2. Dilute 1 mM Phosphate Standard provided by the Universal Kinase Activity Kit by adding 40 µL of the 1 mM Phosphate Standard to 360 µL of 1X Assay Buffer for a 100 µM stock. This is the first point of the standard curve.
  3. Complete the standard curve by performing six one-half serial dilutions of the 100 µM Phosphate stock using 1X Assay Buffer. The standard curve has a range of 0.078 to 5 nmol per well.
  4. Prepare Reaction Mixture containing 0.4 mM ATP (supplied in kit) and 0.2 mg/mL Abltide peptide in 1X Assay Buffer.
  5. Dilute rhABL-1 to 33.35 ng/µL in 1X Assay Buffer.
  6. Dilute Coupling Phosphatase 4 (supplied in kit) to10 ng/µL in 1X Assay Buffer.
  7. Load 50 µL of each dilution of the standard curve into a plate. Include a curve blank containing 50 µL of 1X Assay Buffer.
  8. Load 15 µL of the 33.35 ng/µL rhABL-1 into empty wells of the same plate as the curve.  Include a Control containing 15 µL of 1X Assay Buffer.
  9. Add 10 µL of 10 ng/µL Coupling Phosphatase 4 to wells containing enzyme and Control, excluding the standard curve.
  10. Add 25 µL of Reaction Mixture to the wells, excluding the standard curve.
  11. Incubate sealed plate at room temperature for 10 minutes.
  12. Add 30 µL of the Malachite Green Reagent A to all wells.  Mix briefly.
  13. Add 100 µL of deionized water to all wells. Mix briefly.
  14. Add 30 µL of the Malachite Green Reagent B to all wells.  Mix and incubate for 20 minutes at room temperature.
  15. Read plate at 620 nm (absorbance) in endpoint mode.
  16. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

 Phosphate released* (nmol) x (1000 pmol/nmol)
Incubation time (min) x amount of enzyme (µg)

    
*Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control.
** The coupling rate is 0.475 under these conditions. Per Reaction:

  • rhABL-1: 0.5 µg
  • Coupling Phosphatase 4: 0.1 µg
  • ATP: 0.2 mM
  • Abltide peptide: 5 µg

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes